Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    CAH
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Qualitative Research on Women With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Other: Interview
2 Active, not recruiting Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Interventions: Drug: Hydrocortisone;   Drug: Cortisone acetate
3 Recruiting Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
Conditions: Complex Atypical Hyperplasia;   Endometrial Cancer
Intervention: Drug: Metformin
4 Enrolling by invitation Natural History Study of Patients With Excess Androgen
Conditions: Congenital Adrenal Hyperplasia (CAH);   Familial Male-Limited Precocious Puberty (FMPP)
Intervention:
5 Completed Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
Conditions: Endocrine Disease;   Adrenal Insufficiency;   Congenital Adrenal Hyperplasia
Intervention: Drug: Hydrocortisone Modified Release Capsules
6 Unknown  Tweens to Teens Project at Penn State
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Questionnaires/Interviews
7 Completed Study of UK Adults With Congenital Adrenal Hyperplasia.
Condition: Congenital Adrenal Hyperplasia
Intervention:
8 Completed
Has Results
Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
Conditions: Congenital Adrenal Hyperplasia;   21-Hydroxylase Deficiency;   Adrenogenital Syndrome
Interventions: Drug: Chronocort;   Drug: Cortef
9 Unknown  Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Intervention:
10 Completed Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention:
11 Active, not recruiting Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia
Conditions: Adrenal Insufficiency;   Excess Androgen;   Congenital Adrenal Hyperplasia (CAH)
Interventions: Drug: Hydrocortisone (Solucortef);   Device: Insulin pump (Medtronic)
12 Active, not recruiting Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)
Conditions: Hyperplasia;   Endometrial Cancer
Intervention: Device: Levonorgestrel IUD
13 Unknown  Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers
Condition: Adrenal Hyperplasia, Congenital
Intervention:
14 Not yet recruiting Prenatal Dex Study
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Neuropsychological and cognitive assessment
15 Recruiting A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: ATR-101
16 Completed Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal Hyperplasia
Conditions: Congenital Adrenal Hyperplasia;   Healthy
Intervention:
17 Recruiting The Effect of Surgery on Central Aortic Pressure & haEmodynamics Study
Conditions: Abdominal Aortic Aneurysm;   Pulse Wave Analysis;   Risk
Intervention: Other: This observational study will not entail an intervention.
18 Completed Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: Nifedipine
19 Withdrawn Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: NBI-77860
20 Completed Examining Genetic Differences Among People With 21-Hydroxylase Deficiency
Condition: 21-hydroxylase Deficiency
Intervention: Procedure: Hydrocortisone withdrawal

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.